Overview

Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether OraVerse is safe and effective for the reversal of dental anesthesia in children 2 to 5 years of age weighing at least 10 kg.
Phase:
Phase 4
Details
Lead Sponsor:
Novocol Pharmaceutical of Canada, Inc.
Treatments:
Phentolamine